output
20022026
most citedImprovements to the APBS biomolecular solvation software suite

2.6k citations

253 papers

physics.optics2026★ 1 cited

New Method for Path-length Equalization of Long Single-mode Fibers for Interferometry

M. Anderson, J. D. Monnier, K. Ozdowy +2

The ability to use single mode (SM) fibers for beam transport in optical interferometry offers practical advantages over conventional long vacuum pipes. One challenge facing fiber…

astro-ph.IM2026

Sub-diffraction-limited coronagraphic imaging with nano-printed PIAACMC phase masks

Elena Tonucci, Sebastiaan Y. Haffert, Warren B. Foster +22

Imaging Earth-like exoplanets in the habitable zone of their host star is among the main science objectives of future ground-based and space-based observatories. However, the extre…

cs.CY2026

Unsafe at any AUC: Unlearned Lessons from Sociotechnical Disasters for Responsible AI

Joshua A. Kroll, Andrew Smart, R. Stuart Geiger +1

As automated decision-making and data-driven technologies pervade society and are used to manage consequential outcomes, understanding the technology's capabilities, limitations, a…

astro-ph.SR2026

Interferometric Images of the Starspot Evolution of Andromedae

Rachael M. Roettenbacher, John D. Monnier, Heidi Korhonen +21

The evolution of starspots of the giant primaries of RS CVn systems is typically detected indirectly with photometric and spectroscopic monitoring. These observations suggest slowl…

astro-ph.IM2026

Inflight performance and future improvements for the INtegral Field Ultraviolet Spectrographic Experiment, the first far ultraviolet integral field spectrograph

Alex Haughton, Emily M. Witt, Brian T. Fleming +9

Integral field spectroscopy allows for spectral mapping of extended sources in a time efficient manner. An integral field unit (IFU) in the ultraviolet on Habitable Worlds Observat…

q-bio.QM2025

Drug-disease networks and drug repurposing

Austin Polanco, M. E. J. Newman

Repurposing existing drugs to treat new diseases is a cost-effective alternative to de novo drug development, but there are millions of potential drug-disease combinations to be co…